Skip to main content
SpringerLink
Log in

Multidisciplinary approach to selective sentinel lymph node mapping in breast cancer

  • Review Article
  • Published:
Breast Cancer Aims and scope Submit manuscript

Abstract

Although the role of axillary lymph node dissection is controversial with respect to survival benefits, its role as a staging procedure has been well established since nodal involvement is the most reliable prognostic indicator for patients with breast cancer. Selective sentinel lymph node (SLN) dissection is gaining acceptance as a useful staging procedure because it is minimally invasive and spares approximately 70-80% of the patients a more extensive axillary lymph node dissection. The evolving techniques for selective SLN dissection using blue dye and radiotracer methods are reviewed in this article. Based on the classic definition of the breast lymphatic drainage and recently published articles addressing the issue of peritumoral and intradermal injections, a possible new and simplified approach using intradermal injection may identify the axillary SLN more quickly and reliably. This article emphasizes the importance of a multidisciplinary approach in the identification of SLNs by preoperative lymphoscintigraphy performed by expert nuclear medicine physicians, the intraoperative mapping and harvesting of SLNs by well trained surgeons and the meticulous examination of SLNs by experienced pathologists. Therefore, to achieve the highest rate of accuracy regarding SLN status, it is imperative that a multidisciplinary team with close communication and cooperation be formed. The clinical significance of SLNs will be determined by results from follow-up and clinical trials.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

SLN:

sentinel lymph node

References

  1. Cabanas RM: An approach for the treatment of penile carcinoma.Cancer 39:456–466, 1977.

    Article  PubMed  CAS  Google Scholar 

  2. Morton DL, Wen DR, Wong JH,et al: Technical details of intraoperative lymphatic mapping for early stage melanoma.Arch Surg 127:392–399, 1992.

    PubMed  CAS  Google Scholar 

  3. Reintgen DS, Cruse CW, Wells K: The orderly progression of melanoma nodal metastases.Anna Surg 220:759–767, 1994.

    Article  CAS  Google Scholar 

  4. Ross MI, Reintgen DS, Balch C: Selective lymphadenectomy; Emerging role for lymphatic mapping and sentinel node biopsy in the management of early stage melanoma.Semin in Surg Oncol 9:219–223, 1993.

    CAS  Google Scholar 

  5. Krag DN, Meijer SJ, Weaver DL,et al: Minimal-access surgery for staging of malignant melanoma.Arch Surg 130:654–658, 1995.

    PubMed  CAS  Google Scholar 

  6. Thompson JF, McCarthy WH, Bosch CM,et al: Sentinel lymph node status as an indicator of the presence of metastatic melanonma in regional lymph nodes.Melanoma Research 5:255–260, 1995.

    Article  PubMed  CAS  Google Scholar 

  7. Leong SPL, Steinmetz I, Habib FA,et al: Optimal selective sentinel lymph node dissection in primary malignant melanoma.Arch Surg 132:666–673, 1997.

    PubMed  CAS  Google Scholar 

  8. Reintgen DS: Changing standards of surgical care for melanoma patients.Ann Surg Oncol 3:327–328, 1996.

    Article  PubMed  CAS  Google Scholar 

  9. Coit D, Wallack M, Balch C: Society of Surgical Oncology practice guidelines; Melanoma surgical practice guidelines.Oncology 11:1317–1323, 1997.

    PubMed  CAS  Google Scholar 

  10. Emilia JCD, Lawrence W: Sentinel lymph node biopsy in malignant melanoma; The standard of care.J Surg Oncol 65:153–154, 1997.

    Article  PubMed  CAS  Google Scholar 

  11. Houghton A, Coit D, Bloomer W,et al: NCCN melanoma practice guidelines. National Comprehensive Cancer Network.Oncology 12: 153–177, 1998.

    PubMed  CAS  Google Scholar 

  12. Leong SPL: The Role of Sentinel Lymph Node in Human Solid Cancer, In: Devita, Hellman, Rosenberg, eds, PPO Updates, Vol 12, Lippincott-Raven, Philadelphia, 1998.

    Google Scholar 

  13. Bland KI: Enhancing the accuracy for predictors of axillary nodal metastasis in Tl carcinoma of the breast; Role of selective biopsy with lymphatic mapping.J Am Coll Surg 183:262–264, 1996.

    PubMed  CAS  Google Scholar 

  14. Giuliano AE: Mapping a pathway for axillary staging; A personal perspective on the current status of sentinel lymph node dissection for breast cancer.Arch Surg 134:195–199, 1999.

    Article  PubMed  CAS  Google Scholar 

  15. Giuliano AE, Kirgan DM, Guenther JM,et al: Lymphatic mapping and sentinel lymphadenectomy for breast cancer.Ann Surg 220:391–398; discussion 398-401, 1994.

    Article  PubMed  CAS  Google Scholar 

  16. Turner RR, Ollila DW, Krasne DL,et al: Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma.Ann Surg 226:271–276, 1997.

    Article  PubMed  CAS  Google Scholar 

  17. Krag D, Weaver D, Ashikaga T,et al: The sentinel node in breast cancer-a multicenter validation study.N Engl J Med 339:941–946, 1998.

    Article  PubMed  CAS  Google Scholar 

  18. Van Diest P, Torrenga H, Borgstein PJ,et al: Reliability of intraoperative frozen section and imprint cytological investigation of sentinel lymph nodes in breast cancer.Histopathology 35:14–18, 1999.

    Article  PubMed  CAS  Google Scholar 

  19. Veronesi U, Paganelli G, Galimberti V,et al: Sentinelnode biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes.Lancet 349:1864–1867, 1997.

    Article  PubMed  CAS  Google Scholar 

  20. Dowlatshahi K, Fan M, Snider HC,et al: Lymph node micrometastases from breast carcinoma; Reviewing the dilemma.Cancer 80:1188–1197, 1997

    Article  PubMed  CAS  Google Scholar 

  21. Goldhirsch A, Castiglione M: Prognostic importance of occult axillary ltmph node micrometastases from breast cancers. International (Ludwig) Breast Cancer Study Group.Lancet 335:1565–1568, 1990.

    Article  Google Scholar 

  22. Cote R, Peterson HF, Chaiwun B,et al: Role of immunohistochemical detection of lymph node metastases in management of breast cancer. International Breast Cancer Study Group, pp896–900, 1999.

  23. Kelley S, Komorowski RA, Dayer AM: Axillary sentinel lymph node examination in breast carcinoma.Arch Pathol Lab Med 123:533–535, 1999.

    PubMed  CAS  Google Scholar 

  24. Giuliano AE, Jones RC, Brennan M,et al: Sentinel lymphadenectomy in breast cancer.J Clin Oncol 15:2345–2350, 1997.

    PubMed  CAS  Google Scholar 

  25. Schreiber R, Pendas S, Ku NN,et al: Microstaging of breast cancer patients using cytokeratin staining of the sentinel lymph node.Ann Surg Oncol 6:95–101, 1999.

    Article  PubMed  CAS  Google Scholar 

  26. Pendas S, Dauway E, Cox CE,et al: Sentinel node biopsy and cytokeratin staining for the accurate staging of 478 breast cancer patients.Am Surg 65:505–506, 1999.

    Google Scholar 

  27. Czerniecki B, Scheff AM, Callans LS,et al: Immuno histochemistry with pancytokeratins improves the sensitivity of sentinel lymph node biopsy in patients with breast carcinoma.Cancer 85:1098–1103, 1999.

    Article  PubMed  CAS  Google Scholar 

  28. Mcintosh S, Going JJ, Soukop M,et al. Therapuetic implications of the sentinel lymph node in breast cancer [letter]. Lancet 354:570, 1999.

    Article  PubMed  CAS  Google Scholar 

  29. Ku N: Pathological examination of sentinel lymph nodes in breast cancer.Surg Oncol Clin N Am 8:469–479, 1999.

    PubMed  CAS  Google Scholar 

  30. Banks E, Jansen JF, Oberle E, et al Cytokeratin positivity in fine-needle aspirates of melanomas and sarcomas. Diagn Cytopathol 12:230–233, 1995.

    Article  PubMed  CAS  Google Scholar 

  31. Frisman D, Taylor CR: Immunohistologyof the skin; Melanoma, intermediate filament. Immunomicroscopy, Taylor CR, Cote RJ eds, A Diagnostic Tool for the Surgical Pathologist, 19, pp318–341, 1994.

    Google Scholar 

  32. Viale G, Bosari S, Mazzarol G,et al. Intraoperative examination of axillary sentinel lymph nodes in breast carcinoma patients.Cancer 85:2433–2438, 1999.

    Article  PubMed  CAS  Google Scholar 

  33. Cserni G: Metastases in axillary sentinel lymph nodes in breast cancer as detected by intensive histopathol-ogical work up.J Clin Pathol 52:922–924, 1999.

    Article  PubMed  CAS  Google Scholar 

  34. Turner R, Ollila DW, Stern S,et al. Optimal histopathologic examination of the sentinel lymph node for breast carcinoma staging. Am J Surg Pathol 23:263–267, 1999

    Article  PubMed  CAS  Google Scholar 

  35. Cibull M: Handling sentinel lymph node biopsy speci-mens; A work in progress.Arch Pathol Lab Med 123:620–621, 1999.

    PubMed  CAS  Google Scholar 

  36. Chu KU, Turner RR, Hansen NM, et al Do all patiets with sentinel node metastasis from breast carcinoma need complete axillary node dissection? Ann Surg 229:536–541, 1999.

    Article  PubMed  CAS  Google Scholar 

  37. Schoenfeld A, Luqmani Y, Smith D,et al. Detection of breast cancer micrometastases in axillary lymph nodes by using polymerse chain reaction.Cancer Res 54:2986–2990, 1994.

    PubMed  CAS  Google Scholar 

  38. Carter B, Jensen RA Simpson JF, et al Benign transport of breast epithelium into axillary lymph nodes after biopsy. Am J Clin Pathol 113:259–265, 2000.

    Article  PubMed  CAS  Google Scholar 

  39. Miner TJ, Shriver CD, Flicek PR, et al Guidelines for the safe use of radioactive materials during localiza-tion and resection of the sentinel lymph node [see comments].Ann Surg Oncol 6:75–82, 1999.

    Article  PubMed  CAS  Google Scholar 

  40. Glass E, Essner R, Morton DL: Kinetics of three lym-phocintigraphic agents in patients with cutaneous melanoma.JNucl Med 39:1185–1190, 1998.

    CAS  Google Scholar 

  41. Borgstein PJ, Meijer S, Pijpers R: Intradermal blue dye to identify sentinel lymph-node in breast cancer.Lancet 349:1668–1669, 1997.

    Article  PubMed  CAS  Google Scholar 

  42. Giuliano AE: Intradermal blue dye to identify sentinel lymph node in breast cancer. Lancet 350:958, 1997.

    Article  PubMed  CAS  Google Scholar 

  43. Haagensen CD, Feind CR, Herter FP,et al. The Lymphatics in Cancer, WB Saunders Company, Philadelphia, 1972.

    Google Scholar 

  44. Grant RN, Tabah EJ, Adair FE: The surgical signifi-cance of the subareolar plexus in cancer of the breast.Surgery 33:71–78, 1959.

    Google Scholar 

  45. Turner-Warwick RT: The lymphatics of the breast.Br J Surg 46:574–582, 1953.

    Article  Google Scholar 

  46. Sappey MPC: Anatomie, Physiologie, Pathologie des Vaisseaux Lymphatiques Consideres chez Fhomme et les Vertebres, DeLahaye A, Lecrosnier, Paris, 1874.

    Google Scholar 

  47. Rouviere H: Anatomie des Lymphatiques de l’Homme, Masson, Paris, 1932.

    Google Scholar 

  48. Linehan DC, Hill AD, Tran KN,et al. Sentinel lymph node biopsy in breast cancer; Unaltered radioisotope is superior to filtered.J Am Coll Surg 188:377–381, 1999

    Article  PubMed  CAS  Google Scholar 

  49. Klimberg VS, Rubio IT, Henry R,et al. Subareolar versus peritumoral injection for location of the sentinel lymph node.Ann Surg 229:860–864, discussion 864-865, 1999.

    Article  PubMed  CAS  Google Scholar 

  50. Roumen RM, Geuskens LM, Valkenburg JG: In search of the true sentinel node by different injection techniques in breast cancer patients.Eur J Surg Oncol 25:347–51, 1999.

    Article  PubMed  CAS  Google Scholar 

  51. Vendrell-Torne E, Setoain-Quinquer, Domenech-Torne FM: Study of Normal Mammary Lymphatic Drainage Using Radiotracer Isotopes.J Nucl Med 13:801–805, 1972.

    PubMed  CAS  Google Scholar 

  52. Harlow SP, Krag DN, Weaver DL,et al: Extra-axillary sentinel lymph nodes in breast cancer.Breast Cancer 6:159–165, 1999.

    Article  PubMed  Google Scholar 

  53. Leong SPL, Nwakanma L, Achtem TA,et al: Evolving Techniques in the Identification and Harvesting of Breast Cancer Sentinel Lymph Nodes. 2000 (Submitted for Publication).

  54. Cady B: Lymph node metastases; Indicators, but not governors of survival.Arch Surg 119:1067–1072, 1984.

    PubMed  CAS  Google Scholar 

  55. Nemoto T, Vana J, Bedwani RN,et al: Management and survival of female breast cancer; Results of a national survery by the American College of Surgeons.Cancer 45:2917–2924, 1980.

    Article  PubMed  CAS  Google Scholar 

  56. Carter C, Alan C, Henson DE: Relation of tumor size, lymph node status, and survival in 24 740 breast cancer cases.Cancer 63:181–187, 1989.

    Article  PubMed  CAS  Google Scholar 

  57. Fisher B, Wolmark N, Bauer M,et al: The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histological nodal status in carcinoma of the breast.Sur Gynecol Obstet 152:765–772, 1981.

    CAS  Google Scholar 

  58. NIHCC: Treatment of early breast cancer.JAMA 265:391–395, 1991.

    Article  Google Scholar 

  59. Beahrs O,et al: Manual for Staging of Cancer, Lippincott 4th edition, 1992.

  60. Ivens D, Hoe AL, Podd TJ,et al: Assessment of morbidity from complete axillary dissection.Br J Cancer 66:136–138, 1992.

    PubMed  CAS  Google Scholar 

  61. Fisher B, Redmond C, Fisher ER,et al: Ten year results of randomized clinical trial comparing radical masectomy and total masectomy with or without radiation.NEJM 312:674–682, 1985.

    PubMed  CAS  Google Scholar 

  62. CRCWP: Cancer Research Campaign Working Party; Cancer research campaign trial for early breast cancer.Lancet 11:55–60, 1980.

    Google Scholar 

  63. McArdle C, Crawford D, Dykes EH,et al: Adjuvant radiotherapy and chemotherapy in breast cancer.Br J Surg 73:264–266, 1986.

    Article  PubMed  CAS  Google Scholar 

  64. Fisher N, Redmond C,et al: Eight year results of a randomized clinical trial comparing total masectomy and lumpectomy with and without irradiation in the treatment of breast cancer.NEJM 320:822–828, 1989

    PubMed  CAS  Google Scholar 

  65. Rutqvist LE, Petterson D, Johansson H: Adjuvant radiation therapy versus surgery alone in operable breast cancer; Long-term follow-up in a randomized clinical trial.Radiother Oncol 26:104–110, 1993.

    Article  PubMed  CAS  Google Scholar 

  66. Hayward J: The surgeon’s role in primary breast cancer.Breast Cancer Res Treat 1:27–32, 1981.

    Article  PubMed  CAS  Google Scholar 

  67. Langlands A, Prescott RJ, Hamilton T: A clinical trial in the management of operable breast cancer.Br J Surg 67:170–174, 1980.

    Article  PubMed  CAS  Google Scholar 

  68. Cabanes P, Salmon RJ, Vilcoq JR,et al: Value of axillary dissection in addition to lumpectomy and radiotherapy in early brest cancer.Lancet 329:1245–1248, 1992.

    Article  Google Scholar 

  69. White R, Vezeridis MP, Konstadoulakis M,et al: Therapeutic options and results for the management of minimally invasive carcinoma of the breast; Influence of axillary dissection for treatment of T la and Tib lesions.JACS 183:575–522, 1996

    CAS  Google Scholar 

  70. Overgaard M, Hansen PS, Solin LJ,et al: Postoperative radiotherapy in high-risk premenopausal women with breast cancer who recieve adjuvant chemotherapy.N J Eng Med 337:949–955, 1997

    Article  CAS  Google Scholar 

  71. Ragaz J, Jackson SM, Le N,et al: Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer.N Eng J Med 337:956–962, 1997.

    Article  CAS  Google Scholar 

  72. Krag D: The Sentinel Node for Staging Breast Cancer; Current Review.Breast Cancer 6:233–236, 1999.

    Article  PubMed  Google Scholar 

  73. Giuliano AE: See one, do twenty-five, teach one; The implementation of sentinel node dissection in breast cancer.Ann Surg Oncol 6:520–521, 1999.

    Article  PubMed  CAS  Google Scholar 

  74. Cox CE, Bass, Siddarth S,et al: Implementation of new surgical technology; Outcome measures for lymphatic mapping of breast carcinoma.Ann Surg Oncol 6:553–561, 1999.

    Article  PubMed  CAS  Google Scholar 

  75. Krag DN, Weaver DL, Alex JC,et al: Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe.Surg Oncol 2:335–340, 1993.

    Article  PubMed  CAS  Google Scholar 

  76. Pijpers R, Meijer S, Hoekstra OS,et al: Impact of lymphoscintigraphy on sentinel node identification with technetium-99m-colloidal albumin in breast cancer.J Nucl Med 38:366–368, 1997.

    PubMed  CAS  Google Scholar 

  77. Neiweg OE, Kapteijn BA, Peterse JL,et al: Identification of sentinel node in patients with breast carcinoma.Ned Tijdschr Geneeskd 140:2235–2239, 1996.

    Google Scholar 

  78. Schneebaum SSY, Cohen M,et al: Sentinel lymph node localization in breast cancer; A feasibility study. Presented SSO Meeting in Atlanta, GA, 1996.

  79. Guenther JM, Krishnamoorthy M, Tan LR: Sentinel lymphadenectomy for breast cancer in a community managed care setting.Cancer J Sci Am 3:336–340, 1997.

    PubMed  CAS  Google Scholar 

  80. Borgstein P, Pijpers R, Comans EF,et al: Sentinel lymph node biopsy in breast cancer: guidlines and pitfalls of lymphoscintigraphy and gamma probe detection.J Am Coll Surg 186:275–283, 1998

    Article  PubMed  CAS  Google Scholar 

  81. Barnwell J, Arrendonodo, MA, Kollmorgen D,et al: Sentinel lymph node biopsy in breast cancer.Ann Surg Oncol 5:126–130, 1998

    Article  PubMed  CAS  Google Scholar 

  82. O’Hea BHA, El-Shirbiny AM,et al: Sentinel lymph node biopsy in breast cancer; Initial experience at Memorial Sloan-Kettering Cancer Institute.J Am Coll Surg 186:423–427, 1998.

    Article  PubMed  CAS  Google Scholar 

  83. Cox CE, Pendas S, Cox JM,et al: Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer.Ann Surg 227:645–651; discussion 651-653, 1998.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, University of California School of Medicine, San Francisco, USA

    Stanley P. L. Leong

  2. Department of Nuclear Medicine, University of California School of Medicine, San Francisco, USA

    Engene T. Morita

  3. Department of Pathology, University of California School of Medicine, San Francisco, USA

    Patrick A. Treseler

  4. Department of Surgery, University of Hawaii, Honolulu, USA

    Jan H. Wong

Authors
  1. Stanley P. L. Leong
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Engene T. Morita
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Patrick A. Treseler
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jan H. Wong
    View author publications

    You can also search for this author in PubMed Google Scholar

About this article

Cite this article

Leong, S.P.L., Morita, E.T., Treseler, P.A. et al. Multidisciplinary approach to selective sentinel lymph node mapping in breast cancer. Breast Cancer 7, 105–113 (2000). https://doi.org/10.1007/BF02967441

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02967441

Key words

Search

Navigation